LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 7.25
(-0.82%)
CNY 7.25
(-0.82%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.52 Billion CNY | -2.26% |
| 2022 | 2.58 Billion CNY | 9.97% |
| 2021 | 2.35 Billion CNY | -1.47% |
| 2020 | 2.38 Billion CNY | -0.56% |
| 2019 | 2.4 Billion CNY | -4.89% |
| 2018 | 2.52 Billion CNY | 7.41% |
| 2017 | 2.34 Billion CNY | 15.37% |
| 2016 | 2.03 Billion CNY | 49.49% |
| 2015 | 1.36 Billion CNY | 30.17% |
| 2014 | 1.04 Billion CNY | 15.89% |
| 2013 | 903.07 Million CNY | 9.74% |
| 2012 | 822.91 Million CNY | -0.76% |
| 2011 | 829.22 Million CNY | 81.78% |
| 2010 | 456.16 Million CNY | 8.08% |
| 2009 | 422.04 Million CNY | 5.38% |
| 2008 | 400.51 Million CNY | 11.28% |
| 2007 | 359.92 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.52 Billion CNY | -0.02% |
| 2024 Q3 | 2.47 Billion CNY | -0.52% |
| 2024 Q2 | 2.48 Billion CNY | -1.7% |
| 2023 Q3 | 2.56 Billion CNY | -1.37% |
| 2023 FY | 2.52 Billion CNY | -2.26% |
| 2023 Q2 | 2.59 Billion CNY | -4.05% |
| 2023 Q4 | 2.52 Billion CNY | -1.33% |
| 2023 Q1 | 2.7 Billion CNY | 4.67% |
| 2022 Q2 | 2.45 Billion CNY | 0.02% |
| 2022 Q4 | 2.58 Billion CNY | 8.45% |
| 2022 FY | 2.58 Billion CNY | 9.97% |
| 2022 Q1 | 2.45 Billion CNY | 4.38% |
| 2022 Q3 | 2.38 Billion CNY | -2.88% |
| 2021 FY | 2.35 Billion CNY | -1.47% |
| 2021 Q1 | 2.41 Billion CNY | 1.36% |
| 2021 Q2 | 2.47 Billion CNY | 2.36% |
| 2021 Q3 | 2.47 Billion CNY | -0.11% |
| 2021 Q4 | 2.35 Billion CNY | -4.92% |
| 2020 Q2 | 2.36 Billion CNY | 0.13% |
| 2020 Q1 | 2.35 Billion CNY | -1.8% |
| 2020 Q4 | 2.38 Billion CNY | 3.73% |
| 2020 Q3 | 2.3 Billion CNY | -2.51% |
| 2020 FY | 2.38 Billion CNY | -0.56% |
| 2019 Q4 | 2.4 Billion CNY | -1.53% |
| 2019 FY | 2.4 Billion CNY | -4.89% |
| 2019 Q2 | 2.42 Billion CNY | -1.38% |
| 2019 Q1 | 2.45 Billion CNY | -2.54% |
| 2019 Q3 | 2.43 Billion CNY | 0.5% |
| 2018 Q3 | 2.36 Billion CNY | 1.45% |
| 2018 Q1 | 2.31 Billion CNY | -1.3% |
| 2018 FY | 2.52 Billion CNY | 7.41% |
| 2018 Q4 | 2.52 Billion CNY | 6.65% |
| 2018 Q2 | 2.33 Billion CNY | 0.58% |
| 2017 Q3 | 2.19 Billion CNY | 2.09% |
| 2017 Q4 | 2.34 Billion CNY | 6.89% |
| 2017 FY | 2.34 Billion CNY | 15.37% |
| 2017 Q1 | 2.07 Billion CNY | 1.72% |
| 2017 Q2 | 2.15 Billion CNY | 3.93% |
| 2016 Q2 | 1.69 Billion CNY | 3.45% |
| 2016 FY | 2.03 Billion CNY | 49.49% |
| 2016 Q4 | 2.03 Billion CNY | 16.81% |
| 2016 Q3 | 1.74 Billion CNY | 2.89% |
| 2016 Q1 | 1.63 Billion CNY | 20.24% |
| 2015 Q4 | 1.36 Billion CNY | -9.28% |
| 2015 Q1 | 1.49 Billion CNY | 42.55% |
| 2015 Q2 | 1.52 Billion CNY | 2.19% |
| 2015 Q3 | 1.5 Billion CNY | -1.49% |
| 2015 FY | 1.36 Billion CNY | 30.17% |
| 2014 Q4 | 1.04 Billion CNY | 3.56% |
| 2014 FY | 1.04 Billion CNY | 15.89% |
| 2014 Q3 | 1.01 Billion CNY | -0.01% |
| 2014 Q2 | 1.01 Billion CNY | -4.33% |
| 2014 Q1 | 1.05 Billion CNY | 16.99% |
| 2013 Q3 | 888.86 Million CNY | 9.11% |
| 2013 FY | 903.07 Million CNY | 9.74% |
| 2013 Q1 | 807.38 Million CNY | -1.89% |
| 2013 Q2 | 814.61 Million CNY | 0.9% |
| 2013 Q4 | 903.07 Million CNY | 1.6% |
| 2012 Q3 | 784.19 Million CNY | 0.37% |
| 2012 Q2 | 781.28 Million CNY | -0.22% |
| 2012 Q1 | 782.99 Million CNY | -5.58% |
| 2012 FY | 822.91 Million CNY | -0.76% |
| 2012 Q4 | 822.91 Million CNY | 4.94% |
| 2011 Q4 | 829.22 Million CNY | 64.99% |
| 2011 Q3 | 502.59 Million CNY | 0.51% |
| 2011 FY | 829.22 Million CNY | 81.78% |
| 2011 Q2 | 500.03 Million CNY | 0.0% |
| 2010 FY | 456.16 Million CNY | 8.08% |
| 2010 Q4 | 456.16 Million CNY | 0.0% |
| 2009 FY | 422.04 Million CNY | 5.38% |
| 2008 FY | 400.51 Million CNY | 11.28% |
| 2007 FY | 359.92 Million CNY | 0.0% |